Locations:
Search IconSearch
April 20, 2015/Cancer/News & Insight

Maroone Cancer Center Opens at Cleveland Clinic Florida

Donors and community celebrate grand opening

CCFLaCancerblg_690x380

In February, Cleveland Clinic Florida marked the opening of the new Egil and Pauline Braathen Center, a 144,000-square-foot facility housing the expanded Pauline Braathen Neurological Center and Maroone Cancer Center. The celebration began with a special night to recognize the donors whose generosity made the building possible, and a weekend of community health screenings and tours of the facility. Doors officially opened to patients on March 2.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pauline Braathen cuts the ribbon to the entrance of the new building, joined by (L to R) Steven Roshon, MD, Nestor Galvez-Jimenez, MD, and CEO Toby Cosgrove, MD

Pauline Braathen cuts the ribbon to the entrance of the new building, joined by (L to R) Steven Roshon, MD, Nestor Galvez-Jimenez, MD, and CEO Toby Cosgrove, MD

The Maroone Cancer Center was designed with patient-centered features and amenities in mind including advanced diagnostic, radiosurgery and radiotherapy capabilities; a leading-edge family friendly chemotherapy infusion suite; and full-spectrum patient support and services.

“This building was designed to provide hope and world-class care in a time when we see more neurological diseases and cancers than ever as the population ages,” says Wael Barsoum, MD, President of Cleveland Clinic Florida.

Learn more about the Maroone Cancer Center at Cleveland Clinic Florida.

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad